Launch of the Cleveland Clinic CHIP Clinic: Applying Genomic Discovery to Cardiology
Krishna Aragam, Director of Cardiovascular Genomics at Cleveland Clinic, reposted Ohad Oren’s post on LinkedIn:
“Great to see the launch of the Cleveland Clinic Clonal Hematopoiesis of Indeterminate Potential (CHIP) Cardiology Clinic, a new frontier for applying genomic discoveries to cardiovascular medicine.
CHIP represents a powerful example of how genomic variation — in this case somatic (acquired later in life) rather than germline (inherited at birth) — can inform personalized cardiovascular risk and management.
Looking forward to working with Ohad Oren, MD, MPH and the team to advance precision cardiovascular care guided by genomic insights at the Cleveland Clinic Heart, Vascular and Thoracic Institute.”
Quoting Ohad Oren’s post:
“Launching the Cleveland Clinic CHIP Cardiology Clinic, an exciting step toward integrating clonal hematopoiesis into cardiovascular care.
Excited to share my Circulation paper with Dr. Peter Libby, outlining our vision for the growth and development of CHIP Cardiology programs”
Title: Incorporating Management of Clonal Hematopoiesis of Indeterminate Potential Into Cardiovascular Practice
Authors: Ohad Oren, Peter Libby
Stay informed with Hemostasis Today.
-
Jan 12, 2026, 14:46A Behcet Disease with Aortic Thrombosis: Alexandru Stieber Shares A Peculiar Case
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies